Landscapes / Companies

Exelixis not checked

FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
Approved
Next date
XB010, Phase 1 trial completes
Drugs
6
in active trials · 13 in all
Trials
22 active
35 since 2021

Drugs6

DrugHow it worksPartnerStageNext dateDetails
Tyrosine kinase inhibitor
Approved 31 May 2030Phase 3 trial completes
Tyrosine kinase inhibitor
Phase 3 15 Dec 2026soonPhase 3 trial completes
—
Phase 1 23 Nov 2026soonPhase 1 trial completes
—
Phase 1 30 Apr 2027Phase 1 trial completes
—
Phase 1 31 May 2027Phase 1 trial completes
—
Phase 1 30 Nov 2027Phase 1 trial completes

About

No active trial
7 other drugs
SEC filings
None: it does not file with the US SEC
Sources
ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021

Follow Exelixis

Following is part of Solo: you see every change to Exelixis the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in